Royalty Pharma plc (RPRX) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | 760.54M | 827.15M | 702.62M | 363.98M | 596.08M | 742.52M | 703.61M | 658.21M | 664.64M | 772.63M | 573.52M | 607.82M |
| Operating CF Margin % | 120.53% | 132.98% | 115.32% | 62.9% | 104.9% | 125.08% | 124.6% | 122.51% | 117.02% | 129.62% | 106.94% | 112.93% |
| Operating CF Growth % | 27.59% | 11.4% | -0.14% | -44.7% | -10.32% | -3.9% | 22.68% | 8.29% | -35.71% | 35.57% | 6.44% | 5.72% |
| Net Income | 294.69M | 355.91M | 444.21M | 90.64M | 433.43M | 334.35M | 806.36M | 194.38M | -4.27M | 717.59M | 122.08M | 351.34M |
| Depreciation & Amortization | 1.17M | 1.2M | 1.28M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 0 | 125.77M | 72.84M | 90.77M | 515K | 525K | 526K | 681K | 612K | 617K | 581K | 586K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -370.5M | 295.76M | 235.16M | 132.89M | 226.6M | 356.13M | -84.55M | 413.07M | 697.79M | 6.51M | 487.88M | 218.26M |
| Working Capital Changes | 835.18M | 48.51M | -50.88M | 49.69M | -64.48M | 51.52M | -18.72M | 50.08M | -29.5M | 47.91M | -37.02M | 37.63M |
| Change in Receivables | 1.8M | -415K | -1.16M | -3.96M | 3.17M | -2.06M | -1.32M | -1.35M | 178K | 1.27M | -2.68M | 3.21M |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -5.08M | -28.53M | 10.91M | -6.39M | 10.09M | -5.87M | 7.2M | -6K | -3.61M | 4.59M | 3.79M | -888K |
| Cash from Investing | -520.17M | -847.8M | -958.31M | -311.98M | 503.92M | -505.59M | -1.19B | -893.18M | -86.65M | -1B | -450.66M | -63.43M |
| Capital Expenditures | -452.37M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| CapEx % of Revenue | 71.69% | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | -226K | -74.19M | 0 | 0 | 0 | -3.98M | -6.97M | -1.99M | -3.98M | -2.99M |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | -50M | 2.28M | 905K | -164.56M | -13.74M | -21.76M | 11.49M | -44.02M | 4.96M | 2.62M | 4.46M | 0 |
| Cash from Financing | -272.67M | -299.6M | 562.74M | -507.81M | -941.3M | -257.96M | -325.5M | 1.16B | -212M | -231.89M | -1.36B | -347M |
| Debt Issued (Net) | 0 | 0 | 954.48M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1B | 0 |
| Equity Issued (Net) | -50.1M | -80.54M | -146.49M | -291.57M | -708.78M | -52.61M | -97.05M | -80M | 0 | -30.2M | -140.12M | 0 |
| Dividends Paid | -104.49M | -94.34M | -95.31M | -93.24M | -95.36M | -93.66M | -94.06M | -94.94M | -93.81M | -89.34M | -89.75M | -90.61M |
| Share Repurchases | -50.1M | -80.54M | -146.49M | -291.57M | -708.78M | -52.61M | -97.05M | -80M | 0 | -30.2M | -140.12M | 0 |
| Other Financing | -118.08M | -124.72M | -149.94M | -123M | -137.16M | -111.7M | -134.4M | 1.33B | -118.19M | -112.36M | -129.62M | -256.39M |
| Net Change in Cash | -32.3M | -320.25M | 307.04M | -455.81M | 158.69M | -21.03M | -814.59M | 921.64M | 365.99M | -459.44M | -1.24B | 197.39M |
| Free Cash Flow | 760.54M | 827.15M | 702.62M | 363.98M | 596.08M | 742.52M | 703.61M | 658.21M | 664.64M | 772.63M | 573.52M | 607.82M |
| FCF Margin % | 120.53% | 132.98% | 115.32% | 62.9% | 104.9% | 125.08% | 124.6% | 122.51% | 117.02% | 129.62% | 106.94% | 112.93% |
| FCF Growth % | 27.59% | 11.4% | -0.14% | -44.7% | -10.32% | -3.9% | 22.68% | 8.29% | -35.71% | 35.57% | 6.44% | 5.72% |
| FCF per Share | 1.36 | 1.48 | 1.26 | 0.65 | 1.03 | 1.26 | 1.19 | 1.10 | 1.11 | 1.28 | 0.95 | 1.00 |
| FCF Conversion (FCF/Net Income) | 2.58x | 3.86x | 2.44x | 12.06x | 2.50x | 3.57x | 1.29x | 6.45x | 139.10x | 1.56x | 7.95x | 2.67x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |